Related by context. Frequent words. (Click for all words.) 61 aspirin beta blockers 60 nonfatal MI 59 nonfatal myocardial infarction 58 lipid lowering agents 58 myocardial infarction stroke 58 nonfatal stroke 57 cerebrovascular events 57 de ath 56 colon rectum 56 angina chest 56 pyelonephritis 56 gallbladder disease 55 Exclusion criteria 55 myocardial infarctions 55 myocardial infarction MI 55 thromboembolic 55 circulatory diseases 55 elevated LDL cholesterol 55 neurovascular diseases 55 cerebrovascular diseases 54 coronary revascularization 54 Hospitalizations 54 fatal myocardial infarction 54 angiotensin converting enzyme inhibitors 54 NHANES III 54 events MACE 54 lipid lowering drugs 54 repeat revascularization 54 pulmonary embolism PE 54 stroke myocardial infarction 54 Sudden cardiac death 53 infarctions 53 concomitant medications 53 receiving VELCADE 53 hemorrhagic strokes 53 Ischemic 53 lipid lowering therapy 53 composite endpoint 53 confidence interval #.#-#.# 53 atherothrombosis 53 ximelagatran 53 revascularization procedures 53 NYHA Class II 53 pneumonia bronchitis 52 Arrhythmias 52 nonfatal heart 52 chronic obstructive lung 52 thrombolytic therapy 52 lung cancer emphysema 52 cardio vascular disease 52 Hip fractures 52 cardiomyopathies 52 verapamil 52 bronchitis pneumonia 52 carcinoid 52 cardiovascular 51 infarcts 51 thromboembolism 51 NPH insulin 51 ischemic cardiomyopathy 51 undergoing coronary artery 51 comorbid conditions 51 elevated triglycerides 51 advanced adenomas 51 fibrinolysis 51 Inflammatory bowel disease 51 Contraindications 51 lung colorectal 51 cholesterol lowering statins 51 MACCE 51 ST elevation myocardial 51 ischemic strokes 51 hepatic failure 51 hypoxemia 50 TYSABRI treated 50 beta blocker therapy 50 angiotensin receptor blockers 50 cardiac dysfunction 50 enalapril 50 thrombophilia 50 acute coronary 50 logistic regression analysis 50 TAXUS p value 50 highest quintile 50 corticosteroid therapy 50 narrowings 50 cardiovascular morbidity 50 cardiovascular hospitalization 50 serum lipids 50 patients undergoing percutaneous 50 glitazones 50 Baseline characteristics 50 MGUS 50 extrapyramidal symptoms 50 chlorthalidone 50 uncontrolled hypertension 50 thromboembolic events 50 rFVIIa 50 H2 blockers 50 cardiovascular disease 50 carotid stenosis